CAPZB Antikörper (C-Term)
-
- Target Alle CAPZB Antikörper anzeigen
- CAPZB (Capping Protein (Actin Filament) Muscle Z-Line, beta (CAPZB))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Maus, Ratte, Schwein
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CAPZB Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- CAPZB
- Sequenz
- NDLVEALKRK QQC
- Spezifität
- This antibody is expected to be specific for the beta2 isoform of capping protein, found in non-muscle cells and should not recognise the beta1 form.
- Kreuzreaktivität
- Rind (Kuh), Hund, Human, Maus, Schwein, Ratte
- Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Güteklasse
- Verified
- Immunogen
- Peptide with sequence NDLVEALKRKQQC, from the C Terminus of the protein sequence according to NP_004921.1.
- Isotyp
- IgG
- Top Product
- Discover our top product CAPZB Primärantikörper
-
-
- Applikationshinweise
-
Western Blot: Approx 30 kDa band observed in lysates of cell lines Jurkat, HeLa and NIH-3T3 and approx 28 kDa band observed in Mouse, Rat and Pig Heart lysates (calculated MW of 30.6 kDa according to Human NP_004921.1 and 31.3 kDa according to Mouse NP_00103
Peptide ELISA: antibody detection limit dilution 1:32000.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Minimize freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
Reduction in antioxidant enzyme expression and sustained inflammation enhance tissue damage in the subacute phase of spinal cord contusive injury." in: Journal of biomedical science, Vol. 18, pp. 13, (2011) (PubMed).
: "
-
Reduction in antioxidant enzyme expression and sustained inflammation enhance tissue damage in the subacute phase of spinal cord contusive injury." in: Journal of biomedical science, Vol. 18, pp. 13, (2011) (PubMed).
-
- Target
- CAPZB (Capping Protein (Actin Filament) Muscle Z-Line, beta (CAPZB))
- Andere Bezeichnung
- CAPZB (CAPZB Produkte)
- Synonyme
- CAPB antikoerper, CAPPB antikoerper, CAPZ antikoerper, wu:fk65f06 antikoerper, zgc:66149 antikoerper, MGC52754 antikoerper, capzb antikoerper, 1700120C01Rik antikoerper, AI325129 antikoerper, CPB1 antikoerper, CPB2 antikoerper, CPbeat2 antikoerper, CPbeta1 antikoerper, CPbeta2 antikoerper, Cappb1 antikoerper, capping actin protein of muscle Z-line beta subunit antikoerper, capping protein (actin filament) muscle Z-line, beta antikoerper, F-actin-capping protein subunit beta antikoerper, f-actin-capping protein subunit beta antikoerper, capping protein (actin filament) muscle Z-line, beta L homeolog antikoerper, CAPZB antikoerper, capzb antikoerper, AOR_1_1412174 antikoerper, MCYG_05913 antikoerper, VDBG_04956 antikoerper, MGYG_06053 antikoerper, PGTG_03178 antikoerper, Tsp_07516 antikoerper, capzb.L antikoerper, Capzb antikoerper
- Hintergrund
- CAPZB, capping protein (actin filament) muscle Z-line, beta, CAPB, CAPZ, CAPPB, Cap Z, RP4-657E11.7, MGC104401, MGC129749, MGC129750, Cap Z, F-actin capping protein beta subunit
- Gen-ID
- 832, 12345
- NCBI Accession
- NP_004921
- Pathways
- Regulation of Actin Filament Polymerization
-